KYVERNA THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - KYTX
Portfolio Pulse from
Kahn Swick & Foti, LLC has issued a reminder to investors of Kyverna Therapeutics, Inc. about the lead plaintiff deadline for a class action lawsuit related to the company's IPO. Investors with losses over $100,000 have until February 7, 2025, to file.
December 17, 2024 | 2:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kyverna Therapeutics is facing a class action lawsuit related to its February 2024 IPO. Investors with significant losses have a deadline to file as lead plaintiffs.
The class action lawsuit against Kyverna Therapeutics is directly related to its IPO, which could negatively impact investor sentiment and the stock price in the short term. Legal issues often lead to uncertainty and potential financial liabilities.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100